Med Buccale Chir Buccale
Volume 16, Number 3, juillet 2010
|Page(s)||159 - 162|
|Section||Observations cliniques / Case reports|
|Published online||07 April 2010|
Successful treatment of recalcitrant oral pemphigus vulgaris with mycophenolate mofetil
Département de Médecine buccale et Chirurgie buccale, UF 8601, Hôpitaux
Universitaires, Strasbourg, France
2 INSERM Unité 977, 11 rue Humann, Strasbourg, France
3 Département de Parodontologie, Hôpital de Hautepierre, Faculté de Chirurgie Dentaire, Strasbourg, France
Accepted: 1 March 2010
Oral pemphigus vulgaris (OPV) is an intraepithelial autoimmune bullous disease with circulating autoantibodies against desmoglein 3. The disease is difficult to treat and in some cases may be fatal. Mycophenolate mofetil (MMF), a new immunosuppressive drug which selectively inhibits cytotoxic lymphocytes and antibody production by B-lymphocytes was originally used to treat acute graft rejections in renal transplanted patients. The objective of this trial was to assess the therapeutic efficacy of MMF on OPV. One 61 year-old male patient with oral pemphigus confirmed via histopathology, direct and indirect immunoflourescence, was treated with MMF. After the confirmation of the diagnosis, MMF was administered orally in a dose of 2 g daily. Routine laboratory studies and other recommended laboratory tests for MMF were performed at regular intervals. The patient responded very well to the therapy and all lesions healed completely within 4 months. Under a maintenance therapy of 200 mg MMF per day no relapse of the disease occurred for a follow-up period of 3 years. No side-effects were observed. MMF is a safe and effective therapy for oral OPV. More clinical double-blind studies should be performed to confirm our result.
Key words: mycophenolate mofetil / oral pemphigus vulgaris / treatment resistancy
© SFMBCB, 2010
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.